Protective Effects Of Trimetazidine Against Hepatic Warm Ischemia/Reperfusion Injury On Rats

Year 2021, Volume: 38 Issue: 2, 66 - 71, 03.04.2021

Sertaç Ayhan Tevfik Noyan , Sevil Işık , Sibel Köktürk

Abstract

Background/Aims: Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of liver diseases that occur in individuals who do not consume a significant amount of alcohol, and the pathogenesis of NAFLD remains undefined. It was aimed to investigate whether the use of Trimetazidine (TMZ) could reduce warm ischemia-reperfusion (I/R) damage after liver ischemia on an experimental NAFLD model in this experimental study.
Methods: For this aim, Sprague Dawley male rats were separated into 4 groups; control group (group 1, n = 6), sham operated control grup (group 2, n = 6), warm ischemia/reperfusion group (group 3, n=10), and TMZ group (group 4, n=10, administration of TMZ (10 mg/kg) 30-min before fatty liver I/R). The serum oxidant and antioxidant biochemical markers were measured by ELISA methods. The histopathological evaluation was also performed in the hepatocytes.
Results: TMZ was caused to significantly decrease on oxidative stress markers levels which characterized myeloperoxidase (MPO) (p<0.001), nicotinamide adenine dinucleotide phosphate-oxidase (NOX) (p<0.001), and cytochrome C (Cyt-C) (p<0.001), and increase on antioxidant enzyme catalase (CAT) (p<0.001) activity as compared to group 3. However, TMZ was no caused to any significant change in other oxidant markers malondialdehyde (MDA) and 8-hydroxyguanosine (8-OHDG) levels (p> 0.05). While hepatocyte damage as a form of cell groups was observed due to I/R damage, whereas TMZ had caused positive improvements on dilatation of sinusoids, inflammation and the structural integrity of hepatic plaques.
Conclusion: Trimetazidine could be positively contributing effects to the antioxidant defense mechanism and also the survival of cells by protecting mitochondrial integrity.

Keywords

Warm Ischemia, Reperfusion Injury, Non-alcoholic Fatty Liver Disease, Oxidative Stress,, Trimetazidine

Project Number

TT-1501

References

• Abdel-Salam, O.M.E., Mohammed, N.A, Sleem, A., 2011. The effects of trimetazidine on lipopolysaccharide-induced oxidative stress in mice. EXCLI J. 10(1), 162–172.
• Alshammari, G.M., Balakrishnan, A., Chinnasamy, T., 2018. Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats. Biofactors. 44(3), 289-298.
• Ayyildiz, A., Ayyildiz, S., Benli, E., Erdem, H., Cirrik S., Noyan, T., et al., 2016. The effect of oral and intraurethral trimetazidine use on urethral healing. Iran J. Basic Med. Sc. 19(9), 932–939.
• Ben-Mosbah, I., Casillas-Ramírez, A., Xaus C., Serafín, A., Roselló-Catafau, J., Peralta, C., 2006. Trimetazidine: is it a promising drug for use in steatotic grafts? World J. Gastroenterol. 12(6), 908–914.
• Bradley, P.P., Priebat, D.A., Christensen, R.D., Rothstein, G., 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 78(3), 206-209.
• Carmiel-Haggai, M., Cederbaum, A.I., Nieto, N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 19, 136–138.
• Casillas, A., Mosbah, I.B., Ramalho, F., Roselló-Catafau, J., Peralta, C., 2006. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci. 79(20), 1881-1894.
• French, S.W., Miyamoto, K., Ohta, Y., Geoffrion, Y., 2000. Pathogenesis of experimental alcoholic liver disease in the rat. Methods Achiev. Exp. Pathol. 13, 181–207.
• Goth, L., 1992. A simple method for determination of serum catalase activation and revision of reference range. Clin. Chim. Acta. 196(2-3), 143-151.
• Gupta, N.A., Kolachala, V.L., Jiang, R., Abramowsky, C., Shenoi, A., Kosters, A., et al., 2014. Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver. Am. J. Physiol. Gastrointest. Liver Physiol. 307(11), G1088-99.
• Jorgačević, B., Mladenović, D., Ninković, M., Prokić, V., Stanković, M.N., Aleksić, V., et al., 2014. Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. Hum. Exp. Toxicol. 33(7), 701-709.
• Kapoor, M., Sharma, N., Sandhir, R., Nehru, B., 2018. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain. Biomed Pharmacother. 97, 458-472.
• Kato, H., Kuriyama, N., Duarte, S., Clavien, P.A, Busuttil, R.W., Coito, A.J., 2014. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury. J Hepatol. 60(5), 1032-1039.
• Leghi, G.E., Domenici, F.A., Vannucchi, H., 2015. Influence of oxıdatıve stress and obesıty ın patıents wıth nonalcoholıc steatohepatıtıs. Arq. Gastroenterol. 52(3), 228-233.
• Li, X., Liu, J., Lin, L., Wu, J.Q., Li, H.X., Sun, B.J., et.al., 2014. Traditional Chinese medicine shuang shen ning xin attenuates myocardial ischemia/reperfusion injury by preserving of mitochondrial function. Evid. Based Complement Alternat. Med. 2014:180965.
• Liu, B., Ma, Z.Y., Wu, G., Qian, J.M., 2015. Butyrate protects rats from hepatic ischemia/reperfusion injury. Int. J. Clin. Exp. Med. 8(4), 5406–5413.
• Mahfoudh-Boussaid, A., Zaouali, M.A., Hauet, T., Hadj-Ayed, K., Miled, A.H., Ghoul-Mazgar, S, et al., 2012. Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment. J. Biomed. Sci. 19 (1), 71.
• Onay- Besikci, A., Özkan, S.A., 2008. Trimetazidine Revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine. Cardiovasc. Ther. 26(2), 147-165.
• Park, H.S., Jang, J.E., Ko, M.S., Woo, S.H., Kim, B.J., Kim, H.S., et al., 2016. Statins increase mitochondrial and peroxisomal fatty acid oxidation in the liver and prevent non-alcoholic steatohepatitis in mice. Diabetes Metab. J. 40(5), 376-385.
• Prieto, I., Monsalve, M., 2017. ROS homeostasis, a key determinant in liver ischemic-preconditioning Redox Biol. 12, 1020–1025.
• Selzner, N., Selzner, M., Jochum, W., Clavien, P.A., 2003. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J Hepatol. 39(1), 55-61.
• Tao, X., Sun, X., Xu, L., Yin, L., Han, X., Qi, Y., et al., 2016. Total flavonoids from rosa laevigata michx fruit ameliorates hepatic ıschemia/reperfusion injury through inhibition of oxidative stress and inflammation in rats. Nutrients. 8(7), pii E418.
• Tashiro, H., Kuroda, S., Mikuriya, Y., Ohdan, H., 2014. Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery. Surg. Today. 44(9), 1611-1625.
• Yalçın, A.D., Bisgin, A., Erbay, R.H, Oguz, O., Demir, S., Yilmaz, M., et al., 2012. Trimetazidine effect on burn-induced intestinal mucosal injury and kidney damage in rats. Int. J. Burns Trauma. 2(2), 110-117.
• Yoo, J.J., Kim, W., Kim, M.Y., Jun, D.W., Kim, S.G., Yeon, J.E., et al., 2019. Recent research trends and updates on nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 25(1), 1-11.
• Zaouali, M.A., Panisello, A., Lopez, A., Castro, C., Folch, E., Carbonell, T., et al., 2017. GSK3β and VDAC involvement in ER stress and apoptosis modulation during orthotopic liver transplantation. Int. J. Mol. Sci.18(3), 591.